BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14713108)

  • 1. In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.
    Jenkins DE; Yu SF; Hornig YS; Purchio T; Contag PR
    Clin Exp Metastasis; 2003; 20(8):745-56. PubMed ID: 14713108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.
    Jenkins DE; Oei Y; Hornig YS; Yu SF; Dusich J; Purchio T; Contag PR
    Clin Exp Metastasis; 2003; 20(8):733-44. PubMed ID: 14713107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.
    Scatena CD; Hepner MA; Oei YA; Dusich JM; Yu SF; Purchio T; Contag PR; Jenkins DE
    Prostate; 2004 May; 59(3):292-303. PubMed ID: 15042605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis.
    Pan Y; Zhong LJ; Zhou H; Wang X; Chen K; Yang HP; Xiaokaiti Y; Maimaiti A; Jiang L; Li XJ
    Acta Pharmacol Sin; 2012 Jun; 33(6):798-808. PubMed ID: 22669117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic model for human prostate cancer using orthotopic implantation in nude mice.
    Stephenson RA; Dinney CP; Gohji K; Ordóñez NG; Killion JJ; Fidler IJ
    J Natl Cancer Inst; 1992 Jun; 84(12):951-7. PubMed ID: 1378502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
    Chang XH; Fu YW; Na WL; Wang J; Sun H; Cai L
    Anticancer Res; 1999; 19(5B):4199-202. PubMed ID: 10628375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.
    Notting IC; Buijs JT; Que I; Mintardjo RE; van der Horst G; Karperien M; Missotten GS; Jager MJ; Schalij-Delfos NE; Keunen JE; van der Pluijm G
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1581-7. PubMed ID: 15851554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical orthotopic implantation allows high lung and lymph node metastatic expression of human prostate carcinoma cell line PC-3 in nude mice.
    An Z; Wang X; Geller J; Moossa AR; Hoffman RM
    Prostate; 1998 Feb; 34(3):169-74. PubMed ID: 9492844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of bone metastasis.
    Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
    Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model.
    Hafeez BB; Zhong W; Fischer JW; Mustafa A; Shi X; Meske L; Hong H; Cai W; Havighurst T; Kim K; Verma AK
    Mol Oncol; 2013 Jun; 7(3):428-39. PubMed ID: 23273564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-like factor 4 mediates lysophosphatidic acid-stimulated migration and proliferation of PC3M prostate cancer cells.
    Shin SH; Kwon YW; Heo SC; Jeong GO; Kim BR; Seo EJ; Kim JH
    Exp Mol Med; 2014 Jul; 46(7):e104. PubMed ID: 24993134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models.
    Sun H; Pisle S; Gardner ER; Figg WD
    Cancer Biol Ther; 2010 Jul; 10(1):38-43. PubMed ID: 20495381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality imaging and preclinical evaluation of 177Lu-AMBA for human prostate tumours in a murine model.
    Liu IH; Chang CH; Ho CL; Chiu SP; Lee WC; Chang TJ; Chen LC; Wu YH; Chuang CH; Fu YK; Lee TW
    Anticancer Res; 2010 Oct; 30(10):4039-48. PubMed ID: 21036718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.
    Rahim S; Minas T; Hong SH; Justvig S; Çelik H; Kont YS; Han J; Kallarakal AT; Kong Y; Rudek MA; Brown ML; Kallakury B; Toretsky JA; Üren A
    PLoS One; 2014; 9(12):e114260. PubMed ID: 25479232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niraparib Shows Superior Tissue Distribution and Efficacy in a Prostate Cancer Bone Metastasis Model Compared with Other PARP Inhibitors.
    Snyder LA; Damle R; Patel S; Bohrer J; Fiorella A; Driscoll J; Hawkins R; Stratton CF; Manning CD; Tatikola K; Tryputsen V; Packman K; Mamidi RNVS
    Mol Cancer Ther; 2022 Jul; 21(7):1115-1124. PubMed ID: 35499386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
    van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
    Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.